128 related articles for article (PubMed ID: 36482567)
1. Association of low-density lipoprotein cholesterol levels with the risk of mortality and cardiovascular events: A meta-analysis of cohort studies with 1,232,694 participants.
Peng K; Li X; Wang Z; Li M; Yang Y
Medicine (Baltimore); 2022 Dec; 101(48):e32003. PubMed ID: 36482567
[TBL] [Abstract][Full Text] [Related]
2. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
3. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
[TBL] [Abstract][Full Text] [Related]
5. Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.
Navarese EP; Robinson JG; Kowalewski M; Kolodziejczak M; Andreotti F; Bliden K; Tantry U; Kubica J; Raggi P; Gurbel PA
JAMA; 2018 Apr; 319(15):1566-1579. PubMed ID: 29677301
[TBL] [Abstract][Full Text] [Related]
6. Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population.
Rong S; Li B; Chen L; Sun Y; Du Y; Liu B; Robinson JG; Bao W
J Am Heart Assoc; 2022 Aug; 11(15):e023690. PubMed ID: 35904192
[TBL] [Abstract][Full Text] [Related]
7. Fixed-dose combination therapy for the prevention of cardiovascular disease.
de Cates AN; Farr MR; Wright N; Jarvis MC; Rees K; Ebrahim S; Huffman MD
Cochrane Database Syst Rev; 2014 Apr; 4(4):CD009868. PubMed ID: 24737108
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-density lipoprotein cholesterol on cardiovascular disease and all-cause mortality in elderly patients (≥75 years old).
Yu J; Liu X; Chen S; Liu Y; Liu H; Zheng H; Yang N; Wu S; Li Y
Endocrine; 2022 Feb; 75(2):418-426. PubMed ID: 34618323
[TBL] [Abstract][Full Text] [Related]
9. Statins for the primary prevention of cardiovascular disease.
Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795
[TBL] [Abstract][Full Text] [Related]
10. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
[TBL] [Abstract][Full Text] [Related]
11. High-sensitivity C-reactive protein and low-density lipoprotein cholesterol association with incident of cardiovascular events: Isfahan cohort study.
Nafari A; Mohammadifard N; Haghighatdoost F; Nasirian S; Najafian J; Sadeghi M; Roohafza H; Sarrafzadegan N
BMC Cardiovasc Disord; 2022 May; 22(1):241. PubMed ID: 35614388
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.
Sabatine MS; Wiviott SD; Im K; Murphy SA; Giugliano RP
JAMA Cardiol; 2018 Sep; 3(9):823-828. PubMed ID: 30073316
[TBL] [Abstract][Full Text] [Related]
13. Association of baseline LDL-C with total and cardiovascular mortality in patients using proprotein convertase subtilisin-kexin type 9 inhibitors: A systematic review and meta-analysis.
Khan SU; Riaz H; Rahman H; Khan MU; Khan MS; Alkhouli M; Kaluski E; Leucker TM; Blaha MJ
J Clin Lipidol; 2019; 13(4):538-549. PubMed ID: 31278046
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipoprotein levels as predictors of cardiovascular death in women.
Bass KM; Newschaffer CJ; Klag MJ; Bush TL
Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
[TBL] [Abstract][Full Text] [Related]
15. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
[TBL] [Abstract][Full Text] [Related]
16. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults.
Zhao Y; Delaney JA; Quek RG; Gardin JM; Hirsch CH; Gandra SR; Wong ND
Clin Cardiol; 2016 Jul; 39(7):413-20. PubMed ID: 27177347
[TBL] [Abstract][Full Text] [Related]
18. Low density lipoprotein cholesterol and all-cause mortality rate: findings from a study on Japanese community-dwelling persons.
Kawamoto R; Kikuchi A; Akase T; Ninomiya D; Kumagi T
Lipids Health Dis; 2021 Sep; 20(1):105. PubMed ID: 34511127
[TBL] [Abstract][Full Text] [Related]
19. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
